| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biodiversity | 21 | 2022 | 35 | 7.820 |
Why?
|
| Trees | 18 | 2023 | 18 | 5.400 |
Why?
|
| Laparoscopy | 26 | 2020 | 160 | 4.870 |
Why?
|
| Ecosystem | 17 | 2022 | 22 | 4.820 |
Why?
|
| Exercise Test | 27 | 2023 | 120 | 4.410 |
Why?
|
| Cardiorespiratory Fitness | 10 | 2022 | 16 | 4.120 |
Why?
|
| General Surgery | 13 | 2020 | 47 | 3.870 |
Why?
|
| Gastroplasty | 11 | 2014 | 23 | 3.090 |
Why?
|
| Veterans | 9 | 2023 | 64 | 3.050 |
Why?
|
| Exercise | 13 | 2022 | 451 | 2.350 |
Why?
|
| Obesity, Morbid | 9 | 2014 | 98 | 2.290 |
Why?
|
| Cardiovascular Diseases | 9 | 2023 | 333 | 2.070 |
Why?
|
| Exercise Tolerance | 12 | 2021 | 33 | 1.710 |
Why?
|
| Forests | 11 | 2022 | 11 | 1.700 |
Why?
|
| Models, Biological | 11 | 2021 | 306 | 1.650 |
Why?
|
| Internship and Residency | 6 | 2021 | 206 | 1.640 |
Why?
|
| Heart Failure | 6 | 2017 | 181 | 1.620 |
Why?
|
| Humans | 108 | 2023 | 26286 | 1.620 |
Why?
|
| Male | 79 | 2023 | 14162 | 1.470 |
Why?
|
| Retrospective Studies | 43 | 2022 | 3367 | 1.410 |
Why?
|
| Adult | 53 | 2023 | 7448 | 1.350 |
Why?
|
| Middle Aged | 66 | 2021 | 8601 | 1.350 |
Why?
|
| Risk Factors | 28 | 2023 | 2265 | 1.320 |
Why?
|
| Quality of Life | 4 | 2021 | 621 | 1.290 |
Why?
|
| Postoperative Complications | 18 | 2017 | 869 | 1.270 |
Why?
|
| Aged | 55 | 2021 | 8765 | 1.260 |
Why?
|
| Female | 73 | 2021 | 14539 | 1.260 |
Why?
|
| Seeds | 6 | 2023 | 7 | 1.250 |
Why?
|
| Clinical Clerkship | 5 | 2015 | 21 | 1.220 |
Why?
|
| Pinus | 4 | 2018 | 4 | 1.150 |
Why?
|
| Educational Measurement | 4 | 2015 | 53 | 1.100 |
Why?
|
| United States | 21 | 2022 | 1990 | 1.080 |
Why?
|
| Image-Guided Biopsy | 2 | 2018 | 32 | 1.070 |
Why?
|
| Biomass | 4 | 2022 | 4 | 1.050 |
Why?
|
| Risk Assessment | 17 | 2022 | 629 | 1.030 |
Why?
|
| Smoking | 5 | 2019 | 170 | 1.030 |
Why?
|
| Oxygen Consumption | 11 | 2021 | 36 | 0.970 |
Why?
|
| Stomach Neoplasms | 3 | 2017 | 24 | 0.970 |
Why?
|
| Plants | 5 | 2023 | 6 | 0.920 |
Why?
|
| Hyperlipidemias | 1 | 2023 | 14 | 0.880 |
Why?
|
| Dyslipidemias | 1 | 2023 | 16 | 0.870 |
Why?
|
| Follow-Up Studies | 23 | 2019 | 1738 | 0.850 |
Why?
|
| Students, Medical | 2 | 2013 | 42 | 0.850 |
Why?
|
| Weight Loss | 7 | 2014 | 120 | 0.840 |
Why?
|
| Treatment Outcome | 29 | 2022 | 3391 | 0.830 |
Why?
|
| Gastrointestinal Stromal Tumors | 2 | 2017 | 29 | 0.820 |
Why?
|
| Clinical Competence | 5 | 2020 | 210 | 0.820 |
Why?
|
| Physicians | 2 | 2021 | 108 | 0.790 |
Why?
|
| Predictive Value of Tests | 16 | 2019 | 460 | 0.790 |
Why?
|
| Heart Rate | 6 | 2019 | 108 | 0.780 |
Why?
|
| Plant Dispersal | 3 | 2021 | 3 | 0.760 |
Why?
|
| Herniorrhaphy | 7 | 2016 | 29 | 0.760 |
Why?
|
| Spondylolisthesis | 1 | 2022 | 42 | 0.750 |
Why?
|
| Hypertension | 3 | 2021 | 223 | 0.750 |
Why?
|
| Climate Change | 5 | 2022 | 13 | 0.740 |
Why?
|
| Physical Fitness | 6 | 2021 | 57 | 0.740 |
Why?
|
| Societies, Medical | 1 | 2021 | 146 | 0.720 |
Why?
|
| Surgeons | 1 | 2021 | 79 | 0.720 |
Why?
|
| Proportional Hazards Models | 11 | 2019 | 326 | 0.710 |
Why?
|
| Spinal Diseases | 1 | 2022 | 114 | 0.710 |
Why?
|
| Birds | 1 | 2020 | 5 | 0.700 |
Why?
|
| Hernia, Hiatal | 3 | 2014 | 9 | 0.700 |
Why?
|
| Renal Dialysis | 1 | 2021 | 108 | 0.690 |
Why?
|
| Prospective Studies | 13 | 2023 | 1668 | 0.680 |
Why?
|
| Postoperative Hemorrhage | 1 | 2019 | 21 | 0.660 |
Why?
|
| Fibrinolytic Agents | 1 | 2019 | 56 | 0.650 |
Why?
|
| Hernia, Ventral | 4 | 2016 | 19 | 0.650 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 151 | 0.640 |
Why?
|
| Patient Safety | 2 | 2016 | 51 | 0.630 |
Why?
|
| Surgical Mesh | 4 | 2014 | 22 | 0.630 |
Why?
|
| Neoplasms | 2 | 2019 | 222 | 0.620 |
Why?
|
| Surgical Procedures, Operative | 2 | 2019 | 25 | 0.610 |
Why?
|
| Lymph Nodes | 2 | 2018 | 62 | 0.610 |
Why?
|
| Ecology | 4 | 2022 | 4 | 0.600 |
Why?
|
| Esophagogastric Junction | 1 | 2017 | 12 | 0.580 |
Why?
|
| Soil | 5 | 2023 | 6 | 0.580 |
Why?
|
| Spinal Fusion | 2 | 2022 | 480 | 0.570 |
Why?
|
| North America | 6 | 2022 | 38 | 0.560 |
Why?
|
| Forecasting | 1 | 2017 | 90 | 0.560 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2017 | 40 | 0.560 |
Why?
|
| Mycorrhizae | 3 | 2023 | 3 | 0.550 |
Why?
|
| Poaceae | 2 | 2018 | 4 | 0.550 |
Why?
|
| Kidney Neoplasms | 1 | 2017 | 66 | 0.550 |
Why?
|
| Cholecystectomy, Laparoscopic | 5 | 2015 | 31 | 0.540 |
Why?
|
| Biota | 3 | 2015 | 4 | 0.540 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 36 | 0.520 |
Why?
|
| Plant Development | 2 | 2020 | 3 | 0.520 |
Why?
|
| Surveys and Questionnaires | 8 | 2021 | 1074 | 0.520 |
Why?
|
| Altitude | 2 | 2015 | 2 | 0.510 |
Why?
|
| Writing | 1 | 2015 | 18 | 0.500 |
Why?
|
| Hospitals | 1 | 2016 | 150 | 0.500 |
Why?
|
| Quality Improvement | 6 | 2021 | 151 | 0.500 |
Why?
|
| Fires | 2 | 2012 | 2 | 0.490 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2017 | 176 | 0.490 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 21 | 0.490 |
Why?
|
| Population Dynamics | 6 | 2016 | 10 | 0.490 |
Why?
|
| Abdominal Neoplasms | 1 | 2014 | 12 | 0.480 |
Why?
|
| Insurance, Health | 1 | 2014 | 18 | 0.480 |
Why?
|
| Lymphoma | 1 | 2014 | 36 | 0.480 |
Why?
|
| Carbon Dioxide | 2 | 2017 | 19 | 0.470 |
Why?
|
| Radiography, Abdominal | 1 | 2014 | 4 | 0.460 |
Why?
|
| Specialties, Surgical | 1 | 2013 | 2 | 0.450 |
Why?
|
| Aptitude Tests | 1 | 2013 | 2 | 0.450 |
Why?
|
| Animals, Laboratory | 1 | 2013 | 1 | 0.450 |
Why?
|
| Fertility | 6 | 2023 | 17 | 0.450 |
Why?
|
| Seedlings | 3 | 2018 | 4 | 0.440 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2013 | 28 | 0.440 |
Why?
|
| Pulmonary Ventilation | 2 | 2012 | 10 | 0.430 |
Why?
|
| Education, Medical | 1 | 2013 | 38 | 0.430 |
Why?
|
| Databases, Factual | 10 | 2021 | 333 | 0.420 |
Why?
|
| Logistic Models | 10 | 2016 | 365 | 0.410 |
Why?
|
| Population Density | 4 | 2018 | 7 | 0.410 |
Why?
|
| Environment | 2 | 2012 | 41 | 0.400 |
Why?
|
| Recovery of Function | 5 | 2016 | 283 | 0.400 |
Why?
|
| Motor Activity | 1 | 2014 | 315 | 0.400 |
Why?
|
| Operative Time | 6 | 2019 | 85 | 0.380 |
Why?
|
| Colectomy | 3 | 2016 | 17 | 0.370 |
Why?
|
| Fluoroscopy | 2 | 2010 | 53 | 0.360 |
Why?
|
| Pilot Projects | 5 | 2019 | 378 | 0.360 |
Why?
|
| Endosonography | 2 | 2007 | 9 | 0.350 |
Why?
|
| Radiography, Interventional | 1 | 2010 | 22 | 0.350 |
Why?
|
| Aged, 80 and over | 14 | 2021 | 4675 | 0.340 |
Why?
|
| Animals | 10 | 2020 | 3538 | 0.340 |
Why?
|
| Geography | 4 | 2022 | 18 | 0.340 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2009 | 7 | 0.340 |
Why?
|
| Cholelithiasis | 1 | 2009 | 9 | 0.340 |
Why?
|
| Gastric Outlet Obstruction | 1 | 2009 | 3 | 0.340 |
Why?
|
| Gastrectomy | 3 | 2017 | 29 | 0.340 |
Why?
|
| Cardiovascular System | 2 | 2019 | 15 | 0.330 |
Why?
|
| Tropical Climate | 4 | 2021 | 4 | 0.330 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2019 | 6 | 0.330 |
Why?
|
| Conservation of Natural Resources | 2 | 2021 | 2 | 0.310 |
Why?
|
| Multivariate Analysis | 8 | 2017 | 305 | 0.310 |
Why?
|
| Anastomotic Leak | 2 | 2019 | 7 | 0.300 |
Why?
|
| Cardiac Rehabilitation | 3 | 2021 | 8 | 0.300 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 104 | 0.300 |
Why?
|
| Formaldehyde | 2 | 1998 | 9 | 0.300 |
Why?
|
| Omentum | 1 | 2007 | 8 | 0.300 |
Why?
|
| Rectum | 2 | 1998 | 43 | 0.300 |
Why?
|
| Climate | 4 | 2022 | 6 | 0.290 |
Why?
|
| Prognosis | 11 | 2019 | 758 | 0.290 |
Why?
|
| Reproduction | 3 | 2023 | 9 | 0.290 |
Why?
|
| Obesity | 3 | 2022 | 279 | 0.290 |
Why?
|
| Biological Evolution | 2 | 2018 | 9 | 0.290 |
Why?
|
| Cause of Death | 3 | 2017 | 57 | 0.280 |
Why?
|
| Survival Rate | 7 | 2017 | 322 | 0.280 |
Why?
|
| Missouri | 3 | 2018 | 27 | 0.280 |
Why?
|
| Comorbidity | 5 | 2016 | 475 | 0.270 |
Why?
|
| Liposarcoma | 1 | 2006 | 16 | 0.270 |
Why?
|
| Diffusion of Innovation | 1 | 2006 | 30 | 0.270 |
Why?
|
| Education, Medical, Graduate | 2 | 2020 | 73 | 0.270 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2006 | 36 | 0.270 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2006 | 57 | 0.260 |
Why?
|
| Education, Medical, Continuing | 1 | 2006 | 34 | 0.260 |
Why?
|
| Time Factors | 12 | 2019 | 1391 | 0.260 |
Why?
|
| Incidence | 2 | 2019 | 716 | 0.260 |
Why?
|
| Pancreatic Neoplasms | 1 | 2006 | 67 | 0.260 |
Why?
|
| Cholecystolithiasis | 1 | 2005 | 2 | 0.260 |
Why?
|
| Mouthwashes | 1 | 2005 | 6 | 0.250 |
Why?
|
| Gastroesophageal Reflux | 1 | 2005 | 25 | 0.250 |
Why?
|
| Endoscopy | 2 | 2021 | 176 | 0.250 |
Why?
|
| Triglycerides | 2 | 2023 | 40 | 0.240 |
Why?
|
| Lung | 2 | 2018 | 155 | 0.240 |
Why?
|
| Pneumonia | 3 | 2016 | 70 | 0.230 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2016 | 162 | 0.230 |
Why?
|
| Deer | 1 | 2004 | 2 | 0.230 |
Why?
|
| Blood Pressure | 5 | 2019 | 199 | 0.230 |
Why?
|
| Soil Microbiology | 2 | 2021 | 3 | 0.230 |
Why?
|
| Health Policy | 2 | 2021 | 49 | 0.220 |
Why?
|
| Wood | 2 | 2022 | 2 | 0.220 |
Why?
|
| Chi-Square Distribution | 6 | 2013 | 134 | 0.220 |
Why?
|
| Body Mass Index | 5 | 2013 | 427 | 0.220 |
Why?
|
| Cholesterol, HDL | 1 | 2023 | 23 | 0.220 |
Why?
|
| Cholesterol, LDL | 1 | 2023 | 25 | 0.220 |
Why?
|
| Cholesterol | 1 | 2023 | 43 | 0.220 |
Why?
|
| Feasibility Studies | 3 | 2019 | 210 | 0.220 |
Why?
|
| Movement | 1 | 2004 | 110 | 0.220 |
Why?
|
| Adolescent | 7 | 2019 | 2080 | 0.210 |
Why?
|
| Heart Diseases | 2 | 2016 | 57 | 0.210 |
Why?
|
| Laparotomy | 1 | 2002 | 19 | 0.210 |
Why?
|
| Abdominal Muscles | 1 | 2002 | 7 | 0.210 |
Why?
|
| Curriculum | 2 | 2020 | 140 | 0.210 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 679 | 0.200 |
Why?
|
| Young Adult | 6 | 2021 | 1886 | 0.200 |
Why?
|
| Peripheral Arterial Disease | 2 | 2012 | 5 | 0.200 |
Why?
|
| Telemedicine | 3 | 2021 | 98 | 0.200 |
Why?
|
| Species Specificity | 4 | 2016 | 42 | 0.200 |
Why?
|
| Drug Prescriptions | 1 | 2021 | 25 | 0.190 |
Why?
|
| Blood Transfusion | 3 | 2019 | 65 | 0.190 |
Why?
|
| Regeneration | 1 | 2021 | 20 | 0.190 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2015 | 70 | 0.190 |
Why?
|
| Carbon Sequestration | 1 | 2021 | 1 | 0.190 |
Why?
|
| Carbon | 1 | 2021 | 8 | 0.190 |
Why?
|
| Computer Simulation | 2 | 2020 | 196 | 0.190 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 9 | 0.190 |
Why?
|
| Decompression, Surgical | 1 | 2002 | 129 | 0.190 |
Why?
|
| Propofol | 1 | 2021 | 9 | 0.190 |
Why?
|
| Delirium | 1 | 2021 | 10 | 0.180 |
Why?
|
| Information Dissemination | 1 | 2021 | 17 | 0.180 |
Why?
|
| Respiratory Function Tests | 2 | 2012 | 33 | 0.180 |
Why?
|
| Healthy Lifestyle | 1 | 2021 | 34 | 0.180 |
Why?
|
| Health Care Costs | 1 | 2021 | 66 | 0.180 |
Why?
|
| Health Education | 1 | 2021 | 44 | 0.180 |
Why?
|
| Chest Pain | 2 | 2018 | 22 | 0.180 |
Why?
|
| ROC Curve | 2 | 2013 | 137 | 0.180 |
Why?
|
| Biomedical Research | 1 | 2021 | 60 | 0.180 |
Why?
|
| Anastomosis, Surgical | 2 | 2017 | 26 | 0.170 |
Why?
|
| Cohort Studies | 7 | 2015 | 1838 | 0.170 |
Why?
|
| Carcinoma | 2 | 2016 | 60 | 0.170 |
Why?
|
| Smokers | 1 | 2019 | 11 | 0.170 |
Why?
|
| Simulation Training | 1 | 2020 | 38 | 0.170 |
Why?
|
| Hernia, Inguinal | 2 | 2016 | 16 | 0.170 |
Why?
|
| Age Factors | 4 | 2017 | 753 | 0.170 |
Why?
|
| Survival Analysis | 6 | 2015 | 235 | 0.170 |
Why?
|
| Electrocardiography | 4 | 2013 | 112 | 0.170 |
Why?
|
| Intraoperative Care | 2 | 2019 | 39 | 0.160 |
Why?
|
| Microbiota | 1 | 2020 | 91 | 0.160 |
Why?
|
| Arteriovenous Malformations | 1 | 2019 | 3 | 0.160 |
Why?
|
| Sleep | 2 | 2019 | 256 | 0.160 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 210 | 0.160 |
Why?
|
| Intestinal Diseases | 1 | 2019 | 9 | 0.160 |
Why?
|
| Hypoxia | 1 | 2019 | 34 | 0.160 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2019 | 21 | 0.160 |
Why?
|
| Colonic Neoplasms | 2 | 2016 | 51 | 0.160 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 43 | 0.160 |
Why?
|
| Patient Satisfaction | 3 | 2013 | 311 | 0.160 |
Why?
|
| Ixodidae | 1 | 2018 | 1 | 0.160 |
Why?
|
| Pulmonary Veins | 1 | 2019 | 32 | 0.160 |
Why?
|
| Infant | 2 | 2019 | 520 | 0.160 |
Why?
|
| Child, Preschool | 2 | 2019 | 593 | 0.150 |
Why?
|
| Diaphragm | 1 | 2018 | 8 | 0.150 |
Why?
|
| Atrial Fibrillation | 2 | 2013 | 153 | 0.150 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 309 | 0.150 |
Why?
|
| Foreign-Body Migration | 1 | 2018 | 19 | 0.150 |
Why?
|
| Self Report | 1 | 2019 | 204 | 0.150 |
Why?
|
| Scoliosis | 1 | 2018 | 32 | 0.150 |
Why?
|
| Southwestern United States | 1 | 2017 | 1 | 0.150 |
Why?
|
| Northwestern United States | 1 | 2017 | 3 | 0.150 |
Why?
|
| Antibiosis | 1 | 2017 | 2 | 0.150 |
Why?
|
| Multimorbidity | 1 | 2017 | 7 | 0.140 |
Why?
|
| Child | 3 | 2019 | 1236 | 0.140 |
Why?
|
| Infant, Newborn | 1 | 2019 | 593 | 0.140 |
Why?
|
| Geriatric Assessment | 1 | 2019 | 204 | 0.140 |
Why?
|
| Nephrectomy | 1 | 2017 | 30 | 0.140 |
Why?
|
| Urinary Retention | 1 | 2017 | 10 | 0.140 |
Why?
|
| Surgical Stapling | 1 | 2017 | 5 | 0.140 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2017 | 4 | 0.140 |
Why?
|
| Europe | 1 | 2017 | 66 | 0.140 |
Why?
|
| California | 4 | 2013 | 27 | 0.140 |
Why?
|
| Alcoholism | 1 | 2017 | 64 | 0.140 |
Why?
|
| Mobile Applications | 1 | 2017 | 24 | 0.140 |
Why?
|
| Lumbar Vertebrae | 1 | 2022 | 411 | 0.140 |
Why?
|
| Bolivia | 2 | 2015 | 3 | 0.140 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 78 | 0.130 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2016 | 5 | 0.130 |
Why?
|
| Enterostomy | 1 | 2016 | 5 | 0.130 |
Why?
|
| Observer Variation | 1 | 2016 | 93 | 0.130 |
Why?
|
| Secondary Prevention | 1 | 2016 | 54 | 0.130 |
Why?
|
| Hospitalization | 1 | 2019 | 294 | 0.130 |
Why?
|
| Heart | 2 | 2010 | 70 | 0.130 |
Why?
|
| Magnoliopsida | 1 | 2015 | 1 | 0.130 |
Why?
|
| Pollination | 1 | 2015 | 1 | 0.130 |
Why?
|
| Ventricular Function, Left | 2 | 2013 | 42 | 0.130 |
Why?
|
| Stroke Volume | 2 | 2013 | 62 | 0.130 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 347 | 0.130 |
Why?
|
| Fundoplication | 2 | 2013 | 18 | 0.130 |
Why?
|
| End Stage Liver Disease | 1 | 2015 | 10 | 0.130 |
Why?
|
| Certification | 1 | 2015 | 45 | 0.130 |
Why?
|
| Surgical Instruments | 2 | 2007 | 21 | 0.130 |
Why?
|
| Exercise Therapy | 1 | 2016 | 95 | 0.130 |
Why?
|
| Plant Physiological Phenomena | 1 | 2015 | 1 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 133 | 0.120 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 126 | 0.120 |
Why?
|
| Job Application | 1 | 2015 | 7 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 66 | 0.120 |
Why?
|
| Gallbladder Neoplasms | 1 | 2015 | 4 | 0.120 |
Why?
|
| Gastroscopy | 1 | 2015 | 7 | 0.120 |
Why?
|
| Gastrostomy | 1 | 2015 | 6 | 0.120 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2014 | 309 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2016 | 128 | 0.120 |
Why?
|
| Diabetes Mellitus | 3 | 2017 | 126 | 0.120 |
Why?
|
| Appendectomy | 1 | 2014 | 15 | 0.120 |
Why?
|
| Quality of Health Care | 1 | 2016 | 121 | 0.120 |
Why?
|
| Environmental Monitoring | 1 | 2014 | 8 | 0.120 |
Why?
|
| Medical History Taking | 1 | 2014 | 26 | 0.120 |
Why?
|
| Appendicitis | 1 | 2014 | 17 | 0.120 |
Why?
|
| Cardiovascular Agents | 1 | 2014 | 25 | 0.120 |
Why?
|
| Program Evaluation | 2 | 2013 | 125 | 0.120 |
Why?
|
| Analysis of Variance | 3 | 2012 | 252 | 0.120 |
Why?
|
| Occupational Health | 1 | 2014 | 16 | 0.120 |
Why?
|
| Odds Ratio | 5 | 2015 | 265 | 0.120 |
Why?
|
| Prosthesis Failure | 1 | 2018 | 506 | 0.120 |
Why?
|
| Credentialing | 1 | 2014 | 7 | 0.110 |
Why?
|
| Biliary Dyskinesia | 1 | 2013 | 2 | 0.110 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2013 | 4 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2014 | 28 | 0.110 |
Why?
|
| Walking | 1 | 2016 | 257 | 0.110 |
Why?
|
| Preoperative Period | 1 | 2014 | 78 | 0.110 |
Why?
|
| Elective Surgical Procedures | 1 | 2014 | 37 | 0.110 |
Why?
|
| Rest | 1 | 2013 | 29 | 0.110 |
Why?
|
| Gallbladder Diseases | 1 | 2013 | 4 | 0.110 |
Why?
|
| Cholecystectomy | 1 | 2013 | 16 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 936 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 1 | 2015 | 141 | 0.110 |
Why?
|
| Heart Failure, Systolic | 1 | 2013 | 6 | 0.110 |
Why?
|
| Abdominal Wall | 1 | 2013 | 6 | 0.110 |
Why?
|
| Quercus | 1 | 2012 | 1 | 0.110 |
Why?
|
| Carya | 1 | 2012 | 1 | 0.110 |
Why?
|
| Health Promotion | 1 | 2014 | 147 | 0.100 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 159 | 0.100 |
Why?
|
| Sepsis | 1 | 2014 | 138 | 0.100 |
Why?
|
| Anxiety | 1 | 2013 | 136 | 0.100 |
Why?
|
| Registries | 3 | 2021 | 177 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2013 | 566 | 0.100 |
Why?
|
| Louisiana | 1 | 2012 | 1 | 0.100 |
Why?
|
| Flowers | 1 | 2012 | 1 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2012 | 132 | 0.100 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 485 | 0.100 |
Why?
|
| Esophageal Achalasia | 1 | 2012 | 17 | 0.100 |
Why?
|
| Foreign Bodies | 1 | 1992 | 28 | 0.100 |
Why?
|
| Ileal Neoplasms | 1 | 2011 | 1 | 0.100 |
Why?
|
| Recreation | 1 | 2011 | 3 | 0.100 |
Why?
|
| Reoperation | 3 | 2016 | 879 | 0.090 |
Why?
|
| Esophagus | 1 | 2012 | 62 | 0.090 |
Why?
|
| Health Status | 1 | 2012 | 215 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2013 | 212 | 0.090 |
Why?
|
| Water | 1 | 2011 | 29 | 0.090 |
Why?
|
| Illinois | 2 | 2014 | 231 | 0.090 |
Why?
|
| Length of Stay | 4 | 2014 | 304 | 0.090 |
Why?
|
| Melanoma | 1 | 2011 | 48 | 0.090 |
Why?
|
| Phylogeny | 2 | 2021 | 46 | 0.090 |
Why?
|
| Reference Standards | 2 | 2021 | 23 | 0.090 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2010 | 29 | 0.090 |
Why?
|
| Demography | 1 | 2011 | 71 | 0.090 |
Why?
|
| Skin Neoplasms | 1 | 2011 | 67 | 0.090 |
Why?
|
| Coronary Circulation | 1 | 2010 | 24 | 0.090 |
Why?
|
| Methylene Blue | 1 | 2010 | 1 | 0.090 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2010 | 1 | 0.090 |
Why?
|
| Ventricular Function | 1 | 2009 | 13 | 0.090 |
Why?
|
| Duodenostomy | 1 | 2009 | 2 | 0.080 |
Why?
|
| Jejunostomy | 1 | 2009 | 6 | 0.080 |
Why?
|
| Conscious Sedation | 1 | 2009 | 6 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 78 | 0.080 |
Why?
|
| Safety | 1 | 2009 | 39 | 0.080 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2009 | 53 | 0.080 |
Why?
|
| Ambulatory Care Facilities | 1 | 2009 | 36 | 0.080 |
Why?
|
| Neutropenia | 1 | 2008 | 17 | 0.080 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2010 | 73 | 0.080 |
Why?
|
| Stomach Diseases | 1 | 2008 | 2 | 0.080 |
Why?
|
| Pancreatic Cyst | 1 | 2008 | 3 | 0.080 |
Why?
|
| Models, Theoretical | 2 | 2021 | 78 | 0.080 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2008 | 32 | 0.080 |
Why?
|
| Administration, Rectal | 2 | 1998 | 2 | 0.080 |
Why?
|
| Ischemia | 1 | 2007 | 21 | 0.070 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2007 | 8 | 0.070 |
Why?
|
| Bile Ducts | 1 | 2007 | 10 | 0.070 |
Why?
|
| Dogs | 2 | 1998 | 177 | 0.070 |
Why?
|
| Temperature | 2 | 2022 | 58 | 0.070 |
Why?
|
| Splenectomy | 1 | 2006 | 5 | 0.070 |
Why?
|
| Pancreatectomy | 1 | 2006 | 8 | 0.070 |
Why?
|
| Stomach | 1 | 2006 | 13 | 0.070 |
Why?
|
| Pancreas | 1 | 2006 | 28 | 0.070 |
Why?
|
| Intestinal Mucosa | 2 | 1998 | 184 | 0.070 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2006 | 24 | 0.060 |
Why?
|
| Intestines | 2 | 2017 | 94 | 0.060 |
Why?
|
| Prostaglandins F, Synthetic | 1 | 2005 | 2 | 0.060 |
Why?
|
| Glaucoma | 1 | 2005 | 3 | 0.060 |
Why?
|
| Intraocular Pressure | 1 | 2005 | 7 | 0.060 |
Why?
|
| Research Design | 1 | 2007 | 183 | 0.060 |
Why?
|
| Blood Glucose | 2 | 2019 | 99 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 74 | 0.060 |
Why?
|
| Confidence Intervals | 2 | 2015 | 90 | 0.060 |
Why?
|
| Surgical Wound Infection | 2 | 2016 | 82 | 0.060 |
Why?
|
| Plants, Edible | 1 | 2004 | 1 | 0.060 |
Why?
|
| Territoriality | 1 | 2004 | 1 | 0.060 |
Why?
|
| Prostheses and Implants | 1 | 2005 | 159 | 0.060 |
Why?
|
| Symbiosis | 1 | 2023 | 3 | 0.060 |
Why?
|
| Feedback | 1 | 2023 | 29 | 0.060 |
Why?
|
| Satiation | 1 | 2023 | 2 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2004 | 75 | 0.050 |
Why?
|
| Recurrence | 2 | 2014 | 314 | 0.050 |
Why?
|
| Plant Leaves | 1 | 2022 | 3 | 0.050 |
Why?
|
| Compartment Syndromes | 1 | 2002 | 9 | 0.050 |
Why?
|
| Sex Factors | 2 | 2016 | 450 | 0.050 |
Why?
|
| Military Personnel | 1 | 2002 | 28 | 0.050 |
Why?
|
| Microclimate | 1 | 2022 | 1 | 0.050 |
Why?
|
| Uncertainty | 1 | 2022 | 8 | 0.050 |
Why?
|
| Phenotype | 1 | 2022 | 290 | 0.050 |
Why?
|
| South America | 1 | 2021 | 3 | 0.050 |
Why?
|
| Spinal Cord Injuries | 1 | 2002 | 38 | 0.050 |
Why?
|
| Reference Values | 1 | 2021 | 184 | 0.050 |
Why?
|
| Angina Pectoris | 2 | 2016 | 15 | 0.050 |
Why?
|
| Anesthesia, Intravenous | 1 | 2021 | 6 | 0.050 |
Why?
|
| Respiratory Tract Diseases | 1 | 2021 | 6 | 0.050 |
Why?
|
| Organizational Policy | 1 | 2021 | 14 | 0.050 |
Why?
|
| Rehabilitation | 1 | 2021 | 12 | 0.050 |
Why?
|
| Seasons | 1 | 2021 | 21 | 0.050 |
Why?
|
| Anesthesia, General | 1 | 2021 | 28 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 723 | 0.050 |
Why?
|
| Risk Reduction Behavior | 1 | 2021 | 46 | 0.050 |
Why?
|
| Plant Roots | 1 | 2020 | 1 | 0.040 |
Why?
|
| Rhizosphere | 1 | 2020 | 1 | 0.040 |
Why?
|
| Endophytes | 1 | 2020 | 1 | 0.040 |
Why?
|
| Grassland | 1 | 2020 | 1 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2021 | 78 | 0.040 |
Why?
|
| Smoking Cessation | 1 | 2021 | 47 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 47 | 0.040 |
Why?
|
| Lymphokines | 1 | 2000 | 8 | 0.040 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2000 | 8 | 0.040 |
Why?
|
| Endothelial Growth Factors | 1 | 2000 | 9 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2000 | 33 | 0.040 |
Why?
|
| Carbon Cycle | 1 | 2019 | 1 | 0.040 |
Why?
|
| Isoxazoles | 1 | 1999 | 5 | 0.040 |
Why?
|
| Bacteria | 1 | 2020 | 73 | 0.040 |
Why?
|
| Oximetry | 1 | 2019 | 11 | 0.040 |
Why?
|
| International Cooperation | 1 | 2019 | 22 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 1999 | 15 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2021 | 140 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 41 | 0.040 |
Why?
|
| Esophageal Neoplasms | 1 | 2000 | 44 | 0.040 |
Why?
|
| Smartphone | 1 | 2019 | 16 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2021 | 419 | 0.040 |
Why?
|
| United Kingdom | 1 | 2019 | 46 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2019 | 78 | 0.040 |
Why?
|
| Nymph | 1 | 2018 | 1 | 0.040 |
Why?
|
| Larva | 1 | 2018 | 2 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 171 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2000 | 179 | 0.040 |
Why?
|
| Hemoptysis | 1 | 2018 | 7 | 0.040 |
Why?
|
| Compliance | 1 | 1998 | 2 | 0.040 |
Why?
|
| Southeastern United States | 1 | 2018 | 9 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2018 | 22 | 0.040 |
Why?
|
| Proctitis | 1 | 1998 | 3 | 0.040 |
Why?
|
| Manometry | 1 | 1998 | 15 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1998 | 16 | 0.040 |
Why?
|
| Collagen | 1 | 1998 | 81 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 1999 | 177 | 0.040 |
Why?
|
| Radiation Injuries | 1 | 1998 | 26 | 0.040 |
Why?
|
| Lymph Node Excision | 2 | 2015 | 19 | 0.040 |
Why?
|
| Kinetics | 1 | 2017 | 186 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2017 | 72 | 0.040 |
Why?
|
| Tobacco Smoking | 1 | 2016 | 4 | 0.030 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2016 | 5 | 0.030 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1976 | 7 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 144 | 0.030 |
Why?
|
| Satellite Imagery | 1 | 2016 | 1 | 0.030 |
Why?
|
| Remote Sensing Technology | 1 | 2016 | 2 | 0.030 |
Why?
|
| Prevalence | 2 | 2011 | 437 | 0.030 |
Why?
|
| Cholangiography | 1 | 2015 | 11 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2016 | 68 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 49 | 0.030 |
Why?
|
| Hernia, Umbilical | 1 | 2015 | 2 | 0.030 |
Why?
|
| Life Style | 1 | 2017 | 186 | 0.030 |
Why?
|
| Spatial Analysis | 1 | 2015 | 1 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2015 | 7 | 0.030 |
Why?
|
| Perioperative Care | 1 | 2015 | 43 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 64 | 0.030 |
Why?
|
| Morbidity | 1 | 2014 | 55 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 1997 | 574 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 127 | 0.030 |
Why?
|
| Workplace | 1 | 2014 | 14 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 253 | 0.030 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2014 | 19 | 0.030 |
Why?
|
| Hepatectomy | 1 | 2015 | 51 | 0.030 |
Why?
|
| Colonic Diseases | 1 | 2014 | 9 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2015 | 136 | 0.030 |
Why?
|
| Breath Tests | 1 | 2013 | 10 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2013 | 16 | 0.030 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 53 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 314 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2014 | 78 | 0.030 |
Why?
|
| Prosthesis Implantation | 1 | 2013 | 31 | 0.030 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2013 | 37 | 0.030 |
Why?
|
| Wound Healing | 1 | 2014 | 149 | 0.030 |
Why?
|
| Disease Management | 1 | 2014 | 109 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2013 | 89 | 0.030 |
Why?
|
| Hospitals, Veterans | 1 | 2012 | 6 | 0.030 |
Why?
|
| Phylogeography | 1 | 2012 | 1 | 0.030 |
Why?
|
| Italy | 1 | 2012 | 13 | 0.030 |
Why?
|
| Systole | 1 | 2012 | 15 | 0.030 |
Why?
|
| Retroperitoneal Space | 1 | 1992 | 7 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2012 | 24 | 0.030 |
Why?
|
| Heart-Assist Devices | 1 | 2012 | 15 | 0.030 |
Why?
|
| Laparoscopes | 1 | 2011 | 1 | 0.020 |
Why?
|
| Hemostasis, Surgical | 1 | 1991 | 12 | 0.020 |
Why?
|
| Ankle Brachial Index | 1 | 2011 | 2 | 0.020 |
Why?
|
| Prostatectomy | 1 | 1991 | 19 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 2011 | 23 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2011 | 97 | 0.020 |
Why?
|
| Hemorrhage | 1 | 1991 | 78 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 1991 | 64 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2010 | 17 | 0.020 |
Why?
|
| BCG Vaccine | 1 | 1990 | 2 | 0.020 |
Why?
|
| Carcinoma in Situ | 1 | 1990 | 9 | 0.020 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1990 | 14 | 0.020 |
Why?
|
| Switzerland | 1 | 2010 | 8 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 338 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1990 | 28 | 0.020 |
Why?
|
| Spirometry | 1 | 2009 | 11 | 0.020 |
Why?
|
| Polysomnography | 1 | 2009 | 69 | 0.020 |
Why?
|
| Body Composition | 1 | 2009 | 62 | 0.020 |
Why?
|
| Equipment and Supplies | 1 | 2009 | 9 | 0.020 |
Why?
|
| Education, Professional | 1 | 2009 | 8 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1990 | 186 | 0.020 |
Why?
|
| Pharmaceutical Preparations | 1 | 2009 | 9 | 0.020 |
Why?
|
| Documentation | 1 | 2009 | 26 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 38 | 0.020 |
Why?
|
| Teaching | 1 | 2009 | 53 | 0.020 |
Why?
|
| Mortality | 1 | 2009 | 86 | 0.020 |
Why?
|
| Biomarkers | 1 | 2011 | 556 | 0.020 |
Why?
|
| Cysts | 1 | 2008 | 15 | 0.020 |
Why?
|
| Community-Acquired Infections | 1 | 2008 | 68 | 0.020 |
Why?
|
| Emergencies | 1 | 2008 | 34 | 0.020 |
Why?
|
| Device Removal | 1 | 2008 | 83 | 0.020 |
Why?
|
| Patient Selection | 1 | 2009 | 194 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 2007 | 37 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 853 | 0.020 |
Why?
|
| Patient Participation | 1 | 2005 | 49 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 215 | 0.010 |
Why?
|
| Aerospace Medicine | 1 | 2002 | 4 | 0.010 |
Why?
|
| Trauma Severity Indices | 1 | 2002 | 9 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2002 | 34 | 0.010 |
Why?
|
| Thoracic Vertebrae | 1 | 2002 | 93 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 2000 | 9 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2000 | 13 | 0.010 |
Why?
|
| Barrett Esophagus | 1 | 2000 | 7 | 0.010 |
Why?
|
| Esophagectomy | 1 | 2000 | 21 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2000 | 117 | 0.010 |
Why?
|
| Pyrimidine Nucleotides | 1 | 1999 | 1 | 0.010 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1999 | 1 | 0.010 |
Why?
|
| Crotonates | 1 | 1999 | 3 | 0.010 |
Why?
|
| Toluidines | 1 | 1999 | 3 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 1999 | 3 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1999 | 10 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1999 | 13 | 0.010 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 1999 | 10 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1999 | 23 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2000 | 66 | 0.010 |
Why?
|
| Nitriles | 1 | 1999 | 12 | 0.010 |
Why?
|
| Tyrosine | 1 | 1999 | 24 | 0.010 |
Why?
|
| Hydroxybutyrates | 1 | 1999 | 6 | 0.010 |
Why?
|
| Cell Division | 1 | 1999 | 79 | 0.010 |
Why?
|
| Glioma | 1 | 1999 | 19 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2000 | 80 | 0.010 |
Why?
|
| Aniline Compounds | 1 | 1999 | 39 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 116 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1999 | 97 | 0.010 |
Why?
|
| ErbB Receptors | 1 | 1999 | 51 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1999 | 139 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1999 | 124 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1999 | 160 | 0.010 |
Why?
|
| History of Medicine | 1 | 1976 | 1 | 0.010 |
Why?
|
| Tuberculosis, Bovine | 1 | 1976 | 1 | 0.010 |
Why?
|
| Hospitals, Special | 1 | 1976 | 6 | 0.010 |
Why?
|
| Cattle | 1 | 1976 | 135 | 0.010 |
Why?
|
| Mice | 1 | 1999 | 1290 | 0.010 |
Why?
|
| Hematocrit | 1 | 1991 | 13 | 0.010 |
Why?
|
| Pelvis | 1 | 1991 | 30 | 0.010 |
Why?
|
| Administration, Intravesical | 1 | 1990 | 5 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1991 | 123 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1991 | 88 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1990 | 156 | 0.010 |
Why?
|